Renaissance Technologies - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 64 filers reported holding VIRACTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$154
-18.9%
148,199
+9.9%
0.00%
Q2 2023$190
-4.5%
134,799
+7.6%
0.00%
Q1 2023$199
-2.5%
125,299
-10.4%
0.00%
Q4 2022$204
-100.0%
139,787
+45.8%
0.00%
-100.0%
Q3 2022$409,000
+13.0%
95,899
+2.7%
0.00%
Q2 2022$362,000
+58.8%
93,399
+94.6%
0.00%
Q1 2022$228,000
-46.0%
48,000
-58.5%
0.00%
-100.0%
Q4 2021$422,000115,7000.00%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 689,709$1,096,6370.23%
Aisling Capital Management LP 288,571$458,8280.22%
BVF INC/IL 3,614,662$5,747,3130.21%
Rubric Capital Management LP 1,487,385$2,364,9420.06%
HAMILTON LANE ADVISORS LLC 35,791$570.02%
MAI Capital Management 379,468$603,3540.01%
Laurion Capital Management LP 698,000$1,109,8200.01%
TRUST CO OF TOLEDO NA /OH/ 28,000$44,5200.01%
RP Management, LLC 3,700$5,8830.01%
Jasper Ridge Partners, L.P. 92,939$147,7730.01%
View complete list of VIRACTA THERAPEUTICS INC shareholders